Submit Deal

Announced

20 Mar 2025

Keensight Capital to acquire NIOX Group for $417m.

Synopsis

Keensight Capital, a private equity firm, offered to acquire NIOX Group, a medical device company focused on point of care asthma diagnosis, for $417m.

Principals

target

Niox Group

bidder

Keensight Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (10)

vasco litchfield

Managing Director at Lazard

Financial Advisor

target

Deals

£ 10.72 B

Total Value

david weinberg

Director at Lazard

Financial Advisor

target

Deals

£ 14.22 B

Total Value

ian johnson

Executive Chairman at NIOX GROUP

Manager

target

Deal

£ 322 M

Total Value

jonathan emms

Chief Executive Officer at NIOX GROUP

Manager

target

Deal

£ 322 M

Total Value

michael roller

Chief Financial Officer at NIOX GROUP

Manager

target

Deal

£ 322 M

Total Value

dale raine

Managing Director & Co-Head European Healthcare at Lazard

Financial Advisor

target

Deals

£ 4.56 B

Total Value

orgil sedvanchig

Director at Lazard

Financial Advisor

target

Deal

£ 322 M

Total Value

jen boorer

Director at Singer Capital Markets

Broker

target

Deals

£ 1.51 B

Total Value

james fischer

Analyst at Singer Capital Markets

Broker

target

Deals

£ 629 M

Total Value

james todd

Associate at Singer Capital Markets

Broker

target

Deals

£ 503 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy